Proxy Votes Now

Home › Funds › Fidelity › Fidelity Small Cap Growth Index Fund

Fidelity Small Cap Growth Index Fund (FECGX) proxy voting record 2025-2026

Fund family: Fidelity · Filed by FIDELITY SALEM STREET TRUST (CIK 35315) · SEC series S000065750

Ticker: FECGX (C000212598)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,535 with, 29 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 6 FOR, 12 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Fidelity as a whole

The same two figures as Fidelity’s manager page (1,165,189 ballot items across 406 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsFidelityItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.8%8,27194.1%974,562
Backed environmental and social shareholder proposals at US companiesn/a46.8%11,096

Where this fund voted differently from most Fidelity funds

Each ballot item this fund voted is set against the votes of the other Fidelity funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Fidelity funds on 41 items (0.5% of the 8,368 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Fidelity fundsMgmtResult
BETA Technologies, Inc.2026-06-11Election of Directors: John AbeleWithholdFOR — 38 of 43 Fidelity fundsAgainst—
BrightSpring Health Services, Inc.2026-05-21Election of Class II directors: Max LinForWITHHOLD — 35 of 47 Fidelity fundsForPassed (calculated), 76.3% support
NovaGold Resources Inc.2026-05-14Approval of Non-Binding Advisory Vote on Executive Compensation To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers.ForAGAINST — 14 of 17 Fidelity fundsForApproved, 72.5% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 28 of 40 Fidelity fundsAgainstPassed (calculated), 86.6% support
Construction Partners, Inc.2026-03-24Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Craig JenningsForWITHHOLD — 32 of 46 Fidelity fundsForPassed (calculated), 79.8% support
Sanmina Corporation2026-03-09To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers.ForAGAINST — 34 of 51 Fidelity fundsForPassed (calculated), 81.4% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Susan M. TolsonAgainstFOR — 26 of 39 Fidelity fundsAgainstPassed (calculated), 66.4% support
Warby Parker Inc.2026-06-08Election of Directors: Ronald WilliamsWithholdFOR — 23 of 34 Fidelity fundsAgainstElected, 91.5% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: David V. Hedley IIIForAGAINST — 30 of 47 Fidelity fundsForPassed (calculated), 83.5% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: Joseph G. Licata, Jr.ForAGAINST — 30 of 47 Fidelity fundsForPassed (calculated), 81.5% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: Susan A. JohnsonForAGAINST — 30 of 47 Fidelity fundsForPassed (calculated), 83.4% support
Scholar Rock Holding Corporation2026-06-04To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 26 of 40 Fidelity fundsAgainstApproved, 61.7% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Dr. Kennon H. GuglielmoForWITHHOLD — 28 of 44 Fidelity fundsForPassed (calculated), 78.3% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Raymond J. ChessForWITHHOLD — 28 of 44 Fidelity fundsForPassed (calculated), 77.9% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Troy A. ClarkeForWITHHOLD — 28 of 44 Fidelity fundsForPassed (calculated), 78.3% support
IMAX Corporation2026-06-104 wordings Election of Directors Election of the ten nominees for the Board of Directors: Gail BermanForAGAINST — 8 of 10 Fidelity fundsForPassed (calculated), 92.5% support
Tecnoglass Inc.2026-06-16To elect three Class A directors to serve for the ensuing three-year period until their successors are elected and qualified: Anne Louise CarricarteAgainstFOR — 19 of 28 Fidelity fundsAgainstPassed (calculated), 82.3% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: David HodgsonWithholdFOR — 23 of 35 Fidelity fundsAgainstElected, 60.8% support
LifeStance Health Group, Inc.2026-06-02Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: David BourdonForWITHHOLD — 25 of 39 Fidelity fundsForElected, 74.5% support
Tecnoglass Inc.2025-12-19Advisory approval of the compensation for our named executive officers.AgainstFOR — 22 of 34 Fidelity fundsAgainstApproved, 77.5% support
NovaGold Resources Inc.2026-05-14Election of Directors: Daniel Muniz QuintanillaForWITHHOLD — 10 of 14 Fidelity fundsForElected, 91.4% support
NovaGold Resources Inc.2026-05-14Election of Directors: Dr. Elaine Dorward-KingForWITHHOLD — 10 of 14 Fidelity fundsForElected, 91.5% support
NovaGold Resources Inc.2026-05-14Election of Directors: Kalidas MadhavpeddiForWITHHOLD — 10 of 14 Fidelity fundsForElected, 88.8% support
Insight Enterprises, Inc.2026-05-13Advisory vote (non-binding) to approve named executive officer compensation.ForAGAINST — 22 of 39 Fidelity fundsForPassed (calculated), 86.7% support
Kestra Medical Technologies, Ltd.2025-09-03The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Conor HanleyForAGAINST — 13 of 21 Fidelity fundsFor—
Show all 41
Items 26 to 41.
CompanyMeetingItemThis fundMost Fidelity fundsMgmtResult
Kestra Medical Technologies, Ltd.2025-09-03The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Elizabeth KwoForAGAINST — 13 of 21 Fidelity fundsFor—
Immunovant, Inc.2025-08-27To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesWithholdFOR — 16 of 28 Fidelity fundsAgainstElected, 89.5% support
Stoke Therapeutics, Inc.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.ForAGAINST — 17 of 30 Fidelity fundsForPassed (calculated), 72.9% support
Mineralys Therapeutics, Inc.2026-05-21Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H.ForWITHHOLD — 15 of 26 Fidelity fundsForPassed (calculated), 63.3% support
Shoulder Innovations, Inc.2026-06-26The election of the Class I directors: Robert BallForWITHHOLD — 9 of 14 Fidelity fundsFor—
Stoke Therapeutics, Inc.2026-06-03Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D.ForWITHHOLD — 15 of 27 Fidelity fundsForPassed (calculated), 73.0% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: James E. Nave, D.V.M.ForWITHHOLD — 16 of 30 Fidelity fundsForElected, 96.6% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: Robert E. LewisForWITHHOLD — 16 of 30 Fidelity fundsForElected, 96.2% support
TeraWulf Inc.2026-06-09Election of directors: Steven PincusForWITHHOLD — 15 of 28 Fidelity fundsForElected, 92.2% support
Flowco Holdings Inc.2026-05-07The election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and until his/her successors are duly elected and qualified: Joseph R. EdwardsWithholdFOR — 8 of 13 Fidelity fundsAgainstElected, 98.4% support
IonQ, Inc.2026-06-16To approve, on an advisory basis, the compensation of our named executive officers in 2025.ForAGAINST — 12 of 22 Fidelity fundsForApproved, 53.7% support
Arrowhead Pharmaceuticals, Inc.2026-03-19Advisory Vote to Approve Executive Compensation.ForAGAINST — 13 of 24 Fidelity fundsFor—
Workiva Inc.2026-05-28Election of Directors: Michael M. Crow, Ph.D.WithholdFOR — 13 of 24 Fidelity fundsAgainstPassed (calculated), 77.9% support
Stoke Therapeutics, Inc.2026-06-03Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithForWITHHOLD — 14 of 27 Fidelity fundsForPassed (calculated), 86.9% support
Tenable Holdings, Inc.2026-05-13To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: John C. Huffard, Jr.ForWITHHOLD — 12 of 23 Fidelity fundsForElected, 54.4% support
UroGen Pharma Ltd.2026-06-22To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law.AgainstFOR — 5 of 9 Fidelity fundsAgainstApproved, 68.2% support

Download all 41 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 89.2% of this fund’s 8,564 such votes could be given a sector; the other 925 (10.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care1,834100.5%
Consumer Discretionary1,39770.5%
Finance1,21500.0%
Technology1,07830.3%
Industrials88730.3%
Real Estate25700.0%
Energy25000.0%
Utilities17500.0%
Miscellaneous16900.0%
Consumer Staples13043.1%
Telecommunications12410.8%
Basic Materials12300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5,72611
Audit-related1,0640
Say-on-Pay1,0342
Compensation3590
Corporate Governance2449
Capital Structure1252
Extraordinary Transactions990
Shareholder Rights and Defenses221
Other100
Diversity, Equity, and Inclusion22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Bloom Energy CorporationMay 21, 2026$30M80
agilon health, inc.March 17, 2026$28M20
Guardant Health, Inc.June 17, 2026$14M50
Glaukos CorporationMay 28, 2026$10M40
BridgeBio Pharma, Inc.June 22, 2026$9M70
The Ensign Group, Inc.May 13, 2026$8M60
Watts Water Technologies, Inc.May 19, 2026$8M110
Semtech CorporationJune 4, 2026$7M120

Notable votes against management

MeetingCompanyProposalFundMgmt
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
June 3, 2026Power Integrations, Inc.To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposalAgainstFor
May 7, 2026Wolverine World Wide, Inc.Shareholder proposal regarding new climate change polices or practices. Shareholder proposalAgainstFor
May 14, 2026Calix, Inc.To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposalForAgainst
May 12, 2026Group 1 Automotive, Inc.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalAgainstFor
July 11, 2025Brookdale Senior Living Inc.Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft Shareholder proposalWithholdFor
July 11, 2025Brookdale Senior Living Inc.Election of Directors: Ortelius Nominees OPPOSED by the Company: Paula J. Poskon Shareholder proposalWithholdFor
April 22, 2026Bloomin' Brands, Inc.Stockholder Proposal Regarding Disclosure of Employee Retention Demographics Shareholder proposalAgainstFor
April 22, 2026Bloomin' Brands, Inc.Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred Stock Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (8 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

8,688 ballot items at 1,180 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Fidelity Small Cap Growth Index Fund (FECGX) voted at 1,180 shareholder meetings of 1,112 companies, on 8,688 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 29 times. Its most frequent area of disagreement was director elections (11 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than Fidelity's funds as a whole (95.8% against 94.1%). It voted differently from most Fidelity funds on 41 items. 8 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Fidelity’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.